FBIO (Fortress) יחס שווי שוק לשווי בספרים

Fortress Biotech, Inc. (FBIO) generates revenue through the management of subsidiaries, sales of approved drugs, and licensing royalties. The holding model minimizes risk by diversifying development across gene therapy and dermatology. This chart of current share prices on GURU.Markets shows a level of 0.39. Business stability is underpinned by the acquisition of early-stage oncology molecules and a broad patent portfolio, which effectively protects operational activities.

This indicator determines the degree of overvaluation or undervaluation of assets by comparing market value to reported equity. Analyzing the price-to-book ratio allows for the identification of price stabilization points prior to a strong impulse. The metric measures the premium the market is willing to pay for the company's net assets. For Fortress Biotech, Inc. (FBIO), this calculation reflects the value of its complex structure of subsidiary companies. Expertise in molecule licensing creates high intrinsic value, which the market assesses through this indicator.